Author

Rachel L. Edwards

Primary ORCID profile (0000-0002-7928-7440 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Rachel L. EdwardsiD1 paper · Washington University in St. Louis

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:plant (other)· 1

Frequent Co-Authors

Audrey Odom JohniD· 1 shared Avnish Patel· 1 shared Christian FlueckiD· 1 shared Colin J. SutherlandiD· 1 shared David A. BakeriD· 1 shared Donelly A. van SchalkwykiD· 1 shared Franziska Mohring· 1 shared Mark C. FieldiD· 1 shared

Activity by Year

2019-2019 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Audrey Odom JohnORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

MicrobiologybioRxivPreprintApr 30, 2019

Modification of an atypical clathrin-independent AP-2 adaptin complex of Plasmodium falciparum reduces susceptibility to artemisinin

Ryan C. Henrici, Rachel L. Edwards, Martin Zoltner…·Colin J. Sutherland

This study shows that modifying the AP-2 adaptin complex in Plasmodium falciparum reduces susceptibility to artemisinin, suggesting alternative mechanisms of drug resistance beyond pfkelch13 mutations.

DOI 10.1101/621078

plant (other)experimental assay

𝕏 PostBluesky